Stem Cell Research Products - Opportunities, Tools, & Technologies

EXECUTIVE SUMMARY
 
Stem cells are primitive cells found in all multi-cellular organisms that are characterized by self-renewal and the capacity to differentiate into mature cell types. Several broad categories of stem cells exist, including:
 • Embryonic stem cells, derived from blastocysts
 • Perinatal stem cells, obtained during the period immediately before and after birth
 • Adult stem cells, found in adult tissues
 • Induced pluripotent stem cells, produced by genetically reprogramming adults cells
 • Cancer stem cells, which give rise to clonal populations of cells that form tumors or disperse in the body
 
Stem cell research and experimentation have been in process for well over five decades, as stem cells have the unique ability to divide and replicate repeatedly. In addition, their “unspecialized” nature allows them to differentiate into a wide variety of specialized cell types. In a developing embryo, stem cells can differentiate into all of the specialized embryonic tissues. In adult organisms, stem and progenitor cells act as a repair system for the body, replenishing specialized cells.
 
The possibilities arising from these characteristics have resulted in great commercial interest, with potential applications ranging from the use of stem cells in reversal and treatment of disease, to cell therapy, tissue regeneration, bioprinting, drug discovery, toxicology testing, and more. Of interest to clinical researchers is the potential to use stem cells within regenerative medicine, and the pharmaceutical industry is integrating stem cells to conductpharmacological testing on cell-specific tissues. There is also demand for extracellular vesicles (EVs) derived from stem cells, because they can act as intercellular messengers and may be able to exert some types of therapeutic effects.
 
Traditionally, scientists have worked with both embryonic and adult stem cells as research tools. While the appeal of embryonic cells has been their ability to differentiate into any type of cell, there has been significant ethical, moral, and spiritual controversy surrounding their use for research purposes. Although some adult stem cells do have differentiation capacity, it is often limited in nature, which results in fewer options for use. Thus, when induced pluripotent stem cells (iPSCs) were discovered in 2006 by Shinya Yamanaka of Kyoto University in Japan, they represented a promising combination of adult and embryonic stem cell characteristics.
 
iPSCs are adult cells which are isolated and then transformed into embryonic-like stem cells through the manipulation of gene expression and other methods. The first successful generation of iPSCs was via research and experimentation using mouse cells at Kyoto University in Japan. In 2007, a series of follow-up experiments were done at Kyoto University in which human adult cells were transformed into iPSC cells. Nearly simultaneously, a research group led by James Thomson at the University of Wisconsin-Madison accomplished the same feat of deriving iPSC lines from human somatic cells.
To facilitate research resulting from interest in these far-ranging applications, a large and rapidly growing market for stem cells research products has emerged. Today, well over one-hundred companies produceproducts to support the activities of stem cell scientists worldwide. The toolscommercialized by these companies include ones to isolate, expand, culture, differentiate, and characterizestem cells, as well as technologies to enable their production at any scale.
 
Broad categories of stem cell research products include, but are not limited to:
 
 • Stem cell lines (such as iPSCs, MSCs, HSCs, NSCs, and ESCs)
 • Stem cell culture media with supplements
 • Consumables (such as antibodies, consumables in assays, cryoprotective agents and microcarriers)
 • Instruments (such as freezers, bioreactors, cytometry devices, and assay systems)
 • Stem cell services
 Specifically, the following compose the majority of stem cell product sales:
 • Primary antibodies to stem cell antigens
 • Bead-based stem cell separation systems
 • Fluorescent-based labeling and detection
 • Stem cell protein purification and analysis tools
 • Tools for DNA and RNA-based characterization of stem cells
 • Isolation/characterization services
 • Stem cell culture media and reagents
 • Stem cell specific growth factors and cytokines
 • Tools for stem cell gene regulation
 • Mechanisms for in vivoand in vitro stem cell tracking
 • Expansion/differentiation services for stem cell media and RNAi
 • Stem cell lines
 • Done-for-you or done-with-you services

 With market competition growing increasingly fierce, ten of the largest companies selling stem cell research products are:

 
• Thermo Fisher Scientific
 • BD Biosciences, a Division of Becton Dickinson (BD)
 • Merck KGaA
 • MiltenyiBiotec
 • STEMCELL Technologies
 • Lonza Group
 • Takara Bio
 • GE Healthcare Life Sciences
 • FUJIFILM CDI
 • Sigma Aldrich
 
Furthermore there are many specialty vendors of stem cell research products, such as FUJIFILM CDI, ReproCELL and Ncardia (who specialize in iPSC-related products), RoosterBio (who specializes in human MSC-specific products), and Corning (who specializes in Matrigel® products to support pluripotent stem cell culture and cultureware), for example.
 
 Key report findings include:
 
 • Stem cell research applications, including priorities by segment
 • Relative demand for stem cell products, by stem cell type
 • Analysis of stem cell manufacturing technologies, including costs, risks, and the rise of contact manufacturing organizations (CMOs)
 • Analysis of market trends, including opportunities and threats
 • Competitive analysis for 128 market participants composing the global market
 • Market size determination, including detailed segmentation and 5-year projections
 
 Input Sources
 
 The content and statistics contained in this report were compiled using a broad range of sources. These input sources include:
 • Interviews with Stem Cell Executives, completed by BioInformant’s Founder and Analysts
 • Stem Cell Grant Funding Database (RePORT Database, CIRM, MRC, Wellcome Trust – UK)
 • Stem Cell Patent Database (United States Patent and Trade Office, World Intellectual Property Organization)
 • Stem Cell Clinical Trial Database (ClinicalTrials.gov, International Clinical Trials Registry Platform, European Union Clinical Trials Register)
 • Stem Cell Scientific Publication Database (PubMed, Highwire Press, Google Scholar)
 • Stem Cell Product Launch Announcements (Trade Journals, Google News)
 • Stem Cell Industry Events (Google News, Google Alerts)
 • Stem Cell Company News (SEC Filings, Investor Publications, Historic Performance)
 • Social Analytics Platforms (Google Trends, Google Adwords, BuzzSumo)
 • And More
 
The possibilities arising from stem cells have resulted in great commercial interest. The purpose of this report is to reveal market dynamics affecting basic and translational research,clinical and commercial applications, and the rising demand for stem cell research products on a global basis. Importantly, it unveils the identities of leading market competitors and presents a market size breakdown, including detailed segmentation with 5-year projections. Use it toidentify emerging market opportunities, spot new product development opportunities before your competition, and make smarter decisions, faster.
 
As the first and only market research firm to specialize in the stem cell industry, BioInformant research has been cited by the Wall Street Journal, Xconomy, and Vogue Magazine. Headquartered in Washington, DC, BioInformant is strategically positioned near industry lawmakers, the National Institutes of Health (NIH), the U.S. FDA, and the Maryland Biotech Corridor. Serving Fortune 500 leaders that include GE Healthcare, Pfizer, and Goldman Sachs, BioInformant is your global leader in stem cell industry data.
  

 1. REPORT OVERVIEW
 
1.1 Statement of the Report
 1.2 Executive Summary
 
 2. STEM CELL RESEARCH: AN INTRODUCTION
 
2.1 Identification of Stem Cells
 2.2 Species Sources of Stem Cells for Research
 2.3 Culturing Stem Cell Lines
 2.4 Differentiation of Stem Cells
 2.5 Benefits of Stem Cell Research
 2.5.1 Basic Research
 2.5.2 Stem Cells in Drug Discovery
 2.5.3 Disease Modeling
 2.5.4 Stem Cells in Toxicity Screening
 
 3. STEM CELLS MARKERS
 
3.1 Embryonic Stem Cell (ESC) Markers
 3.2 Hematopoietic Stem Cell Markers
 3.3 Cancer Stem Cell Markers
 3.4 Osteoprogenitor Cell Markers
 3.5 Neural Stem Cell Markers
 3.6 Mesenchymal Stem Cell Markers
 3.7 Skin Stem Cell Markers
 
 4. STEM CELL ISOLATION PRODUCTS
 
4.1 Flow Cytometry in Stem Cell Isolation
 4.2 Flow Cyometry Systems
 
 5. ANTIBODIES
 
5.1 Primary Antibodies
 5.2 Secondary Antibodies
 5.3 Recombinant Antibodies
 5.4 Trial Size Antibodies
 5.5 Apoptosis Antibodies
 5.6 Epitope Tag and Fusion Protein Antibodies
 5.7 Isotype CONTrol Antibodies
 5.8 Stem Cell Marker Antibodies
 5.9 Pluripotent Stem Cell Markers Antibody Products
 5.10 Mesenchymal Stem Cell Markers Antibody Products
 5.11 Hematopoietic Stem Cell Markers Antibody Products
 5.12 Neural Stem Cell Marker Antibodies
 5.13 Cancer Stem Cell Marker Antibodies
 5.14 Antibody Production
 5.14.1 Antibody Production and Development Services
 5.14.2 Monoclonal Antibody Production Services
 5.14.3 Polyclonal Antibody Production Services
 5.14.4 Antibody Purification Services
 5.14.5 Antibody Conjugation and Labeling Services
 5.14.6 Hybridoma Services
 5.14.7 Recombinant Antibody Production Services
 5.15 Stem Cell Factor ELISA Kits
 
 6. STEM CELL CULTURE MEDIA
 
6.1 Types of Culture Media
 6.2 Choice of Cell Culture Media
 6.2.1 Recommended Media for Primary Cell Culture
 6.3 Stem Cell Culture Media
 6.3.1 Methylcellulose Media
 6.3.2 Differentiation Media
 6.3.3 Expansion Media
 6.4 Embryonic Stem Cell Media
 6.5 Hematopoietic Stem Cell Media
 6.6 Mesenchymal Stem Cell Media
 6.7 Neural Stem Cell Media
 6.8 Media Supplements for Stem Cell Culture
 6.9 Cell Storage Media
 
 7. BIOREACTORS
 
7.1 Stainless Steel Fixed Bioreactors
 7.2 Single-Use Bioreactors
 7.2.1 Single-Use System Types
 7.2.2 Main Features of Commercial Bioreactors
 7.2.3 Main Differences between Single-Use and Multi-Use Bioreactors
 7.2.4 Microcarriers used in Bioreactors
 
 8. STEM CELL LINES
 
8.1 Use of Stem Cell Lines
 8.2 Types of Stem Cell Lines
 8.2.1 Embryonic Stem Cell Lines (ESC Line)
 8.2.2 Adult Stem Cell Lines
 8.2.3 Induced Pluripotent Stem Cell Lines (iPSC Lines)
 8.3 Commercially Available Stem Cell Lines
 
 9. STEM CELL MANUFACTURING
 
9.1 Institutional Manufacturing of Stem Cells
 9.2 Transition to Commercial Manufacturing of Stem Cells
 9.3 CMOs Involved with Stem Cell Manufacturing
 9.4 Stem Cell Manufacturing Process
 9.4.1 Scale-Up Methods
 9.4.2 Closed Automated Systems
 
 10. COST OF STEM CELL MANUFACTURING
 
10.1 Labor Cost in Manufacturing Stem Cells
 10.2 Cost of Stem Cell Manufacture in a Partially-Automated Facility
 10.3 Cost of Stem Cell Manufacture in a Fully-Automatic Facility
 
 11. STEM CELL RESEARCH PRODUCTS: MARKET ANALYSIS
 
11.1 Global Market for Flow Cytometry Systems used in Cell Culture Studies
 11.1.1 Flow Cytometry Market Share by Company
 11.2 Global Market for Stem Cell Research Antibodies
 11.2.1 Stem Cell Research Antibodies Market Share by Company
 11.3 Market for Stem Cell Assay Products
 11.3.1 Global Market for Stem Cell Assays by Product Segments
 11.4 Global Market for Stem Cell Culture Media
 11.4.1 Stem Cell Culture Media Market Share by Company
 11.5 Global Market for Recombinant Cell Culture Supplements
 11.6 Global Market for Stem Cell Cryopreservation Products
 11.6.1 Market Share of Cryopreservation Products by Type
 11.7 Market for Single-Use Bioreactors in Stem Cell Culture
 11.7.1 Market for Single-Use Bioreactors in Stem Cell Culture by Product Segment
 11.7.2 Single-Use Bioreactor Market Share by Company
 11.7.3 Massive Investments in Single-Use Bioreactors
 11.8 Global Market for Microcarriers used in Cell Culture
 11.9 Market for Induced Pluripotent Stem Cells
 11.9.1 Toxicology Assays using iPSCs
 11.10 Market for Human Mesenchymal Stem Cells (hMSCs)
 11.11 Global Market for Embryonic Stem Cells
 11.12 Global Market for Stem Cells
 11.13 Global Market for Stem Cell Research Products
 11.13.1 Leaders in Consumables and Instruments used in Stem Cell Research
 
 12. COMPANY PROFILES
 
12.1 3D Biotek LLC
 12.1.1 Products
 12.2 Abbexa Ltd.
 12.2.1 Products
 12.3 ABclonal
 12.3.1 Products
 12.4 Abeomics Inc.
 12.4.1 Products
 12.4.2 Services
 12.5 Abnova
 12.5.1 Products
 12.6 Absolute Antibody Ltd.
 12.6.1 Products
 12.7 Agilent Technologies Inc.
 12.7.1 Products
 12.8 Alomone Labs Ltd.
 12.8.1 Products
 12.9 AmProtein – China Inc.
 12.9.1 Products
 12.10 Antigenix America Inc.
 12.10.1 Products
 12.11 Apceth Biopharma GmbH
 12.12.1 Cell Types Offered
 12.12.2 Cell Banking & Formulation
 12.13 Applikon Biotechnology BV
 12.13.1 Products
 12.14 AS ONE INTERNATIONAL, INC.
 12.15 Assaypro
 12.15.1 Products
 12.16 ATCC
 12.16.1 Products
 12.17 Athersys, Inc.
 12.17.1 Multistem
 12.18 Atlas Antibodies AB
 12.18.1 Products
 12.19 ATVIO Biotech, Ltd.
 12.19.1 Services
 12.20 Aviva Systems Biology Corp.
 12.20.1 Products
 12.21 Becton, Dickinson and Company
 12.21.1 Offerings
 12.22 Bio Basic
 12.22.1 Products & Services
 12.23 BioIVT
 12.23.1 Products
 12.23.2 Services
 12.24 BioLegend
 12.24.1 Products
 12.25 BioLife Solutions Inc.
 12.25.1 Products
 12.25.1.1 CryoStor
 12.25.1.2 HypoThermosol
 12.25.1.3 BloodStor
 12.25.1.4 Cell Thawing Media
 12.25.1.5 ThawSTAR Products
 12.26 Bio-Rad Laboratories, Inc.
 12.26.1 Products
 12.27 Biorbyt Ltd.
 12.27.1 Products
 12.28 BioSperix Ltd.
 12.28.1 Products
 12.29 Bioss Antibodies Inc
 12.29.1 Products
 12.30 BioVendor – LaboratorniMedicina A.S
 12.30.1 Products & Services
 12.31 BioVision Inc.
 12.31.1 Products
 12.32 Bio X Cell
 12.32.1 Products
 12.33 Bon Opus Biosciences
 12.33.1 Products
 12.34 BosterBio
 12.34.1 Products
 12.34.2 Services
 12.35 CEDARLANE
 12.35.1 Products
 12.36 Cell Culture Technologies LLC
 12.36.1 Products
 12.36.2 Platforms
 12.37 Cellexus Ltd.
 12.37.1 CellMaker Bioreactors
 12.38 Cell Microsystems Inc.
 12.38.1 Products
 12.39 Cell Signaling Technology Inc.
 12.39.1 Products
 12.40 Celltainer Biotech
 12.40.1 Products
 12.41 ChromoTek GmbH
 12.41.1 Products
 12.42 Cognate BioServices Inc.
 12.42.1 Services
 12.43 Corning Life Sciences
 12.43.1 Products
 12.44 CUSABIO Technology LLC
 12.44.1 Products
 12.45 Cygnus Technologies
 12.45.1 Products
 12.46 Diagenode SA
 12.46.1 Products
 12.47 DWK Life Sciences
 12.47.1 Cell Culture Products
 12.48 EMD Millipore Corp.
 12.48.1 Services
 12.49 enQuireBioReagents
 12.49.1 Products
 12.50 Enzo Lifesciences Inc.
 12.50.1 Products
 12.51 EpiGentek Group Inc.
 12.51.1 Products
 12.52 Eppendorf AG
 12.52.1 Products
 12.53 Eurogentec, S.A.
 12.53.1 Products
 12.54 EXBIO Praha a.s
 12.54.1 Products
 12.55 FabGennix International Inc.
 12.55.1 Products
 12.56 Fitzgerald Industries International
 12.56.1 Products
 12.57 GE Healthcare Bio-Sciences
 12.57.1 Products
 12.58 GeneTex Inc.
 12.58.1 Products
 12.59 GenScript
 12.59.1 Products
 12.60 Greiner Bio-One International GmbH
 12.60.1 Products
 12.61 HemaCare Corporation
 12.61.1 Products
 12.62 HiMedia Laboratories
 12.62.1 Products
 12.63 HuaBio
 12.63.1 Products
 12.63.2 Services
 12.64 Hycult Biotech
 12.64.1 Products
 12.65 HyTest Ltd.
 12.65.1 Products
 12.66 ImmuQuest Ltd.
 12.66.1 Products
 12.67 InSphero AG
 12.67.1 Product
 12.67.1.1 3D InSight Microtissue
 12.68 Invent Biotechnologies Inc.
 12.68.1 Products
 12.68.1.1 Minute Kits
 12.69 InvivoGen
 12.69.1 Products
 12.70 Irvine Scientific, Inc. (FUJIFILM Irvine Scientific, Inc.)
 12.70.1 Products
 12.71 iXCells Biotechnologies
 12.71.1 Products
 12.71.1.1 iPSCs/ESCs
 12.71.1.2 iPSC-Derived Cells
 12.71.1.3 Human Primary Cells
 12.71.1.4 Cell Media & Reagents
 12.72 Kerafast, Inc.
 12.72.1 Products
 12.72.1.1 Antibodies & Secondary Detection Reagents
 12.72.1.2 Buffers & Chemicals
 12.72.1.3 Cell Culture & Transfection Reagents
 12.72.1.4 Cell & Tissue Samples
 12.73 LifeSpanBioSciences Inc.
 12.73.1 Antibodies
 12.74 Lonza AG
 12.74.1 Products & Services
 12.75 Maine Biotechnology Services (BBI Group)
 12.75.1 Services
 12.76 MaSTherCell S.A.
 12.76.1 Services
 12.77 MBL International
 12.77.1 Products
 12.78 MD Biosciences (Bioproducts Division)
 12.78.1 Products
 12.79 MiltenyiBiotec GmbH
 12.79.1 Products
 12.80 Minerva Biotechnologies Corporation
 12.81 Monash Antibody Technologies Facility (MATF)
 12.81.1 Services
 12.82 MP Biomedicals LLC
 12.82.1 Products
 12.83 MyBioSource Inc.
 12.83.1 Products
 12.84 Ncardia AG
 12.84.1 Solutions Offered
 12.85 New England Biolabs
 12.85.1 Products
 12.86 Novasep Holding SAS
 12.86.1 Services
 12.87 NovaTeinBio
 12.87.1 Products
 12.88 Novus Biologicals
 12.88.1 Products
 12.89 NSJ Bioreagents
 12.89.1 Products
 12.90 Octane
 12.90.1 Cocoon
 12.91 PBS Biotech Inc.
 12.91.1 Products
 12.92 PROGEN
 12.92.1 Products
 12.93 PromoCell GmbH
 12.93.1 Products & Services
 12.94 ProSci Inc.
 12.94.1 Products
 12.94.2 Services
 12.95 Proteintech Group Inc.
 12.95.1 Products
 12.96 ProteoGenix
 12.96.1 Products & Services
 12.97 QED Bioscience Inc.
 12.97.1 Products
 12.98 Ray Biotech
 12.98.1 Products
 12.99 Rev MAb Biosciences
 12.99.1 Products
 12.100 Reddot Biotech Inc
 12.100.1 Products
 12.101 R & D Systems
 12.101.1 Products
 12.102 REPROCELL Inc.
 12.102.1 Products
 12.102.2 Services
 12.103 RoosterBio, Inc.
 12.103.1 Products
 12.104 RoslinCT
 12.104.1 Products
 12.105 SAFC Biosciences Inc.
 12.105.1 Products
 12.106 Santa Cruz Biotechnology Inc.
 12.106.1 Products
 12.107 Sartorius AG
 12.107.1 Products
 12.108 ScienCell Research Laboratories
 12.108.1 Products
 12.108.1.1 Primary Cells
 12.108.1.2 Cell Culture Media
 12.108.1.3 Stem Cells
 12.108.1.4 Other Products
 12.109 Sigma-Aldrich Corp.
 12.109.1 Products
 12.110 Signalway Antibody LLC
 12.110.1 Products
 12.111 Sino Biological Inc.
 12.111.1 Antibodies
 12.112 Shanghai Korain Biotech Co., Ltd.
 12.112.1 Products
 12.113 SouthernBiotech
 12.113.1 Products
 12.114 StemBioSys, Inc.
 12.114.1 CELLvo Matrix
 12.114.2 CELLvo Cells
 12.115 STEMCELL Technologies.
 12.115.1 Products
 12.115.1.1 Cell Culture Media and Supplements
 12.115.1.2 Cell Isolation Products
 12.115.1.3 Primary and Cultured Cells
 12.115.1.4 Cell Storage Media
 12.116 Synaptic Systems GmbH
 12.116.1 Products
 12.117 Synthecon Inc.
 12.117.1 Products
 12.117.1.1 3D Cell Culture Bioreactors – Rotary Cell Culture
 12.118 Takara Bio Inc.
 12.118.1 Products
 12.119 Terumo BCT Inc.
 12.119.1 Products & Services
 12.120 Thermo Fisher Scientific Inc
 12.120.1 Products
 12.121 United States Biological
 12.121.1 Products
 12.122 Vitrolife AB
 12.122.1 Products
 12.123 VWR International LLC
 12.123.1 Products
 12.124 Wuxi Donglin Sci & Tech Development Co. Ltd.
 12.124.1 Products
 12.125 Xcellerex (GE Healthcare)
 12.125.1 Products
 12.126 YposKesi, SAS (Genethon)
 12.126.1 Products
 12.127 Zen-Bio, Inc.
 12.127.1 Products
 12.128 Zellwerk GmbH
 12.128.1 Z RP Technology Implant Moldings


List Of Tables

 Table 3.1: Examples of Embryonic Stem Cell Markers and Antibody Suppliers
 Table 3.2: Examples of Hematopoietic Stem Cell Markers and Antibody Suppliers
 Table 3.3: Examples of Cancer Stem Cell Markers and Antibody Suppliers
 Table 3.4: Examples of Osteoprogenitor Cell Markers and Antibody Suppliers
 Table 3.5: Examples of Neural Stem Cell Markers and Antibody Suppliers
 Table 3.6: Examples of Mesenchymal Stem Cell Markers and Suppliers of Antibodies
 Table 3.7: Examples of Skin Stem Cell Markers and Antibody Suppliers
 Table 4.1: Commercially Available Stem Cell Isolation Kits and Suppliers
 Table 4.2: Commercially Available Flow Cytometry Systems
 Table 5.1: Commercially Available Primary Antibodies
 Table 5.2: Commercially Available Secondary Antibodies
 Table 5.3: Commercially Available Recombinant Antibodies
 Table 5.4: Commercially Available Trial Size Antibodies
 Table 5.5: Commercially Available Apoptosis Antibodies
 Table 5.6: Commercially Available Epitope Tag Antibodies
 Table 5.7: Commercially Available Isotype Control Antibodies
 Table 5.8: Pluripotent Stem Cell Markers Antibody Products and Suppliers
 Table 5.9: Mesenchymal Stem Cell Markers Antibody Products
 Table 5.10: Hematopoietic Stem Cell Markers Antibody Products
 Table 5.11: Neural Stem Cell Marker Antibodies
 Table 5.12: Cancer Stem Cell Marker Antibodies
 Table 5.13: Companies Providing Antibody Production and Development Services
 Table 5.14: Companies Providing Monoclonal Antibody Production Services
 Table 5.15: Companies Offering Polyclonal Antibody Production Services
 Table 5.16: Companies Offering Antibody Purification Services
 Table 5.17: Companies Offering Antibody Conjugation and Labeling Services
 Table 5.18: Companies Providing Hybridoma Services
 Table 5.19: Companies Offering Recombinant Antibody Production Services
 Table 5.20: Commercially Available Stem Cell Factor ELISA Kits and Suppliers
 Table 6.1: Types of Natural and Artificial Media
 Table 6.2: Cell Lines and Choice of Culture Media
 Table 6.3: Recommended Media for Primary Cell Culture
 Table 6.4: Companies Offering Stem Cell Culture Media
 Table 6.5: Examples of Methylcellulose Media
 Table 6.6: Commercially Available Stem Cell Differentiation Media
 Table 6.7: Commercially Available Stem Cell Expansion Media
 Table 6.8: Commercially Available Embryonic Stem Cell Media
 Table 6.9: Commercially Available Hematopoietic Stem Cell Media
 Table 6.10: Commercially Available Mesenchymal Stem Cell Media
 Table 6.11: Commercially Available Neural Stem Cell Media
 Table 6.12: Components of Media Supplements
 Table 6.13: Commercially Available Cell Culture Supplements and Vendors
 Table 6.14: Examples of Cell Freezing Media
 Table 7.1: Bioreactors used for Stem Cell Expansion
 Table 7.2: Pros and Cons of Fixed Bioreactors
 Table 7.3: Pros and Cons of Single Use Bioreactors
 Table 7.4: Commercially Available Liter- and Cubic Meter-Scale SUBs
 Table 7.5: Main Features of Commercial Bioreactors
 Table 7.6: Main Differences between Single-Use and Multi-Use Bioreactors
 Table 7.7: Microcarriers used in Bioreactors
 Table 8.1: Examples of Commercially Available Stem Cell Lines
 Table 9.1: Select Institutional Manufacturing Facilities for Stem Cell Manufacture
 Table 9.2: Select CMOs and Their Services in Stem Cell Manufacturing
 Table 9.3: Select Cell Manufacturing Solutions
 Table 9.4: Select Closed Manufacturing Systems
 Table 10.1: Categories of Expenditure in Stem Cell Manufacturing
 Table 10.2: The Impact of Head Count on Labor Cost
 Table 10.3: Cost of Stem Cell Manufacture in a Partially-Automated Facility
 Table 10.4: Cost of Stem Cell Manufacture in a Fully-Automatic Facility
 Table 11.1: Global Market for Flow Cytometry Systems used in Cell Culture through 2026
 Table 11.2: Global Market for Stem Cell Research Antibodies through 2026
 Table 11.3: Global Market for Stem Cell Assays by Geography through 2026
 Table 11.4: Global Market for Stem Cell Media by Geography through 2026
 Table 11.5: Global Market for Recombinant Cell Culture Supplements through 2026
 Table 11.6: Market for Stem Cell Cryopreservation Products by Geography through 2026
 Table 11.7: Global Market for SUBs in Stem Cell Culture by Geography through 2026
 Table 11.8: Global Market for Microcarriers by Geography through 2026
 Table 11.9: Global Market for iPSCs by Geography through 2026
 Table 11.10: Global Market for Mesenchymal Stem Cells by Geography through 2026
 Table 11.11: Global Market for Embryonic Stem Cells by Geography through 2026
 Table 11.12: Global Market for Stem Cells by Cell Typethrough 2026
 Table 11.13: Global Market for Stem Cell Research Products through 2026
 Table 11.14: Major Suppliers of Consumables and Instruments in Stem Cell Research
  


List Of Figures

 Figure 2.1: Research Areas Using Stem Cells
 Figure 2.2: Species Sources of Cells for Stem Cell Research
 Figure 2.3: Disease Areas using Stem Cells for Research/Drug Discovery
 Figure 10.1: Categories of Expenditure in Stem Cell Manufacturing
 Figure 10.2: The Impact of Head Count on Labor Cost
 Figure 10.3: Cost of Stem Cell Manufacture in a Partially-Automated Facility
 Figure 10.4: Cost of Stem Cell Manufacture in a Fully-Automatic Facility
 Figure 11.1: Global Market for Flow Cytometry Systems used in Cell Culture through 2026
 Figure 11.2: Flow Cytometry Market Share by Company
 Figure 11.3: Global Market for Stem Cell Research Antibodies through 2026
 Figure 11.4: Stem Cell Research Antibodies Market Share by Company
 Figure 11.5: Global Market for Stem Cell Assays by Geography through 2026
 Figure 11.6: Global Market for Stem Cell Assays by Product Segments
 Figure 11.7: Global Market for Stem Cell Media by Geography through 2026
 Figure 11.8: Stem Cell Culture Media Market Share by Company
 Figure 11.9: Global Market for Recombinant Cell Culture Supplements through 2026
 Figure 11.10: Global Market for Stem Cell Cryopreservation Products through 2026
 Figure 11.11: Market Share of Cryopreservation Products by Type
 Figure 11.12: Market for SUBs in Stem Cell Culture by Geography through 2026
 Figure 11.13: Market for Single-Use Bioreactors in Stem Cell Culture by Product Segment
 Figure 11.14: Single-Use Bioreactor Market Share by Company
 Figure 11.15: Global Market for Microcarriers by Geography through 2026
 Figure 11.16: Global Market for Induced Pluripotent Stem Cells by Geography through 2026
 Figure 11.17: Relative Use of iPSC-Derived Cell Types in Toxicology Assays
 Figure 11.18: Global Market for Mesenchymal Stem Cells by Geography through 2026
 Figure 11.19: Global Market for Embryonic Stem Cells by Geography through 2026
 Figure 11.20: Global Market for Stem Cells by Geography through 2026
 Figure 11.21: Global Market for Stem Cell Research Products by Type through 2026
 Figure 11.22: Major Suppliers of Consumables and Instruments in Stem Cell Research


Global Stem Cell Therapies Market Research Report 2021-2025

Stem cell therapy is the use of stem cells to treat or prevent a disease or condition.Bone marrow transplant is the most widely used stem-cell therapy, but some therapies derived

USD 3200 View Report

Global Stem Cell Therapies Market Research Report 2021-2025

Stem cell therapy is the use of stem cells to treat or prevent a disease or condition.Bone marrow transplant is the most widely used stem-cell therapy, but some therapies derived

USD 3200 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available